Company Overview of Auven Therapeutics Management L.L.L.P
Key Executives for Auven Therapeutics Management L.L.L.P
|Peter B. Corr Ph.D.||15 Relationships||Co-Founder and Co-Managing General Partner||68|
|Stephen R. Evans-Freke||70 Relationships||Co-Founder and Co-Managing General Partner||62|
|Beth P. Hecht J.D.||6 Relationships||Managing Director, Chief Legal Officer, and Chief Administrative Officer||52|
|Reinaldo M. Diaz||2 Relationships||Partner and Managing Director of Investments and Business Development, U.S.||62|
|Randy Dibbley CPA||No Relationships||Group Controller and Bermuda Branch Manager||--|
|View More Key Executives|
Auven Therapeutics Management L.L.L.P Board Members*
|Name||Board Relationships||Primary Company||Age|
|Donald E. Nickelson||68 Relationships||Fletcher Jones Foundation, The||83|
|Alan G. Levin CPA||32 Relationships||Aceto Corporation||54|
|Anthony H. Wild Ph.D.||37 Relationships||BOWS Pharmaceuticals AG||68|
|Richard U. DeSchutter||53 Relationships||Valeant Pharmaceuticals International, Inc.||75|
|Robert G. Easton J.D.||12 Relationships||Celtic Pharma Management L.P||--|
Auven Therapeutics Management L.L.L.P Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee CPA||Alan G. Levin||32 Relationships||1 Executives|
|Advisory Board||Donald E. Nickelson||68 Relationships||6 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
INDUSTRY EXECUTIVE CHANGESThere is no Executive Change data available.
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.